Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Surg Endosc ; 37(3): 1718-1726, 2023 03.
Artigo em Inglês | MEDLINE | ID: mdl-36207649

RESUMO

BACKGROUND AND AIMS: With the global epidemic of SARS-CoV-2, there has been a growing concern regarding the risk of aerosol exposure to healthcare workers and patients during medical/surgical interventions. The Schlieren device is capable of visualizing fine gas-flows by using refractive index differences in the medium. We aimed to reveal the existence of gas leakage from gastro-intestinal endoscopy system by utilizing Schlieren device and to clarify the factors which relates to the amount of gas leakage. METHODS: The experiments were performed on the excised swine stomach while maintaining a constant pressure environment in the stomach. The System Schlieren (SS100,KatoKoken) was used to visualize possible gas leakages from forceps plugs of endoscopy. We attempted to semi-quantify the leakage by referring to the image of the gas from the forceps plug and by measuring the initial velocity and diffusion area of the leakage. RESULTS: Regardless of the type of forceps plugs, a certain amount of leakage was detected during both insertion and removal of forceps. The initial velocity and the diffusion area of the leakage increased with the increase in intragastric pressure. Semi-quantitative comparison showed that there was a difference in the amount of gas leakage among various forceps plugs. Furthermore, the amount of gas leakage was significantly greater in the forceps plugs that were used repeatedly. CONCLUSION: It was possible to visualize gas leakages from the gastrointestinal endoscope system using the Schlieren optical device. Avoiding too high intragastric pressure and not using deteriorated plugs may reduce the risk of aerosol exposure.


Assuntos
COVID-19 , Dispositivos Ópticos , Animais , Suínos , SARS-CoV-2 , Aerossóis e Gotículas Respiratórios , Endoscopia Gastrointestinal
2.
Gan To Kagaku Ryoho ; 49(2): 214-216, 2022 Feb.
Artigo em Japonês | MEDLINE | ID: mdl-35249065

RESUMO

A male in his forties experiencing epigastric pain visited our hospital and was diagnosed with a large gastric gastrointestinal stromal tumor(GIST)invading pancreatic tail with synchronous multiple liver metastases. We diagnosed as unresectable and started imatinib. Two weeks later, tumor necrosis and penetration were occurred. We performed partial gastrectomy with pancreatic tail resection and splenectomy. During the surgery, we also performed radiofrequency ablation(RFA)on all the liver metastases. After surgery, we immediately resumed imatinib. Four years after surgery, metastatic lesion in liver S4/8 was detected, RFA was performed and Imatinib was continued. Eight years after surgery, a recurrent metastatic lesion of the liver coincident with the previous RFA site was detected. We performed a right hepatic lobectomy and he continued imatinib, Currently, 16 years after the first operation, he is alive under the imatinib continuation. This case demonstrates that the combination of surgery, RFA and imatinib can be effective for prolonging survival in patients with advanced gastric GIST with synchronous multiple liver metastases.


Assuntos
Antineoplásicos , Tumores do Estroma Gastrointestinal , Neoplasias Hepáticas , Neoplasias Gástricas , Antineoplásicos/uso terapêutico , Tumores do Estroma Gastrointestinal/tratamento farmacológico , Tumores do Estroma Gastrointestinal/cirurgia , Hepatectomia , Humanos , Mesilato de Imatinib/uso terapêutico , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/cirurgia , Masculino , Neoplasias Gástricas/tratamento farmacológico , Neoplasias Gástricas/cirurgia
3.
Asian J Endosc Surg ; 15(3): 638-641, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-35108756

RESUMO

An 82-year-old woman underwent laparoscopic partial gastrectomy for fundal gastrointestinal stromal tumor (GIST) in a previous hospital. She visited our hospital for the treatment of recurrence, because two nodules, one each on the gastric suture line and in the peritoneum of the left diaphragm, were pointed out. Imatinib therapy was immediately initiated, and the size of both nodules decreased. However, the one on the gastric suture line showed regrowth after 4 years, which was eventually diagnosed as imatinib-resistant GIST. Hence, laparoscopic partial gastrectomy with peritoneal imatinib-sensitive nodule resection was subsequently performed. Pathologically, the nodule on the gastric suture line was confirmed as a GIST, whereas the other was diagnosed as a hyaline-degenerated GIST. Surgical intervention for imatinib-resistant GISTs has been reported to improve the outcomes of recurrent GISTs. Laparoscopic resection of localized imatinib-resistant GISTs could safely and less invasively be performed in this case; however, caution should be paid to the indication of the approach.


Assuntos
Antineoplásicos , Tumores do Estroma Gastrointestinal , Laparoscopia , Neoplasias Gástricas , Idoso de 80 Anos ou mais , Antineoplásicos/uso terapêutico , Feminino , Gastrectomia , Tumores do Estroma Gastrointestinal/tratamento farmacológico , Tumores do Estroma Gastrointestinal/patologia , Tumores do Estroma Gastrointestinal/cirurgia , Humanos , Mesilato de Imatinib/uso terapêutico , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/tratamento farmacológico , Neoplasias Gástricas/cirurgia , Resultado do Tratamento
4.
Gan To Kagaku Ryoho ; 46(13): 2036-2038, 2019 Dec.
Artigo em Japonês | MEDLINE | ID: mdl-32157051

RESUMO

The patient was a 63-year-old man with a chief complaint. Upper endoscopic examination revealed a semicircular type 2 lesion, sized 24-28 cm, on the incisor teeth and a 3 cm sized elevated lesion directly above the EGJ. When biopsy was performed, squamous cell carcinoma(SCC)was detected. In this case, lymph node metastasis and multiple liver metastases were observed, and diagnosis at the first examination was cT3N2M1(HEP), Stage Ⅳ. After 7 months of chemotherapy, he underwent right thoracic esophageal subtotal resection, 3-field lymph node dissection, posterior mediastinal gastric tube reconstruction, and partial hepatectomy. Despite receiving postoperative chemotherapy, he showed recurrence in the liver(S8). Four additional courses of chemotherapy were administered and partial hepatectomy(S8)was performed, without the appearance of new lesions. He was considered to be cured 1 year and 6months after starting the treatment and was followed- up without chemotherapy. However, 4 months later, chemotherapy was resumed when right adrenal and abdominal wall metastases and liver recurrence(S3)were found. After that, the regimen was modified, and he continued treatment. More than 4 years have passed since the start of treatment, but the treatment has been continued without a decline in ADL.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Esofágicas , Neoplasias Hepáticas , Terapia Combinada , Neoplasias Esofágicas/patologia , Neoplasias Esofágicas/terapia , Hepatectomia , Humanos , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/terapia , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...